Sunitinib Efficacy with Minimal Toxicity in Patient-Derived Retinoblastoma Organoids

RNA sequencing was conducted to generate a drug signature from retinoblastoma organoids, and the effects of drugs on cell cycle progression and proliferative tumor cone restriction were examined.